Pay in 4 interest-free payments of $6.10 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Avg Weight Loss CV Event Reduction Published Studies Half-Life Average body weight reduction of 14.9% over 68 weeks The STEP 1 trial demonstrated that weekly semaglutide 2.4mg produced a mean weight loss of 14.9% compared to 2.4% with placebo, establishing a new benchmark in obesity research
At Brandy Marie Family & Aesthetics , we offer Semaglutide and Tirzepatide two advanced, FDA-approved medications designed to help you manage weight and control blood sugar levels
We believe access to effective weight loss treatment should not be hindered by cost
The potential investment on the PBS into reducing the significant burden of disease and economic burden of obesity could be in the order of multiple billions over the forward estimates, it said
US$ 27.39
US$ 26.48
US$ 27.20
